Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

99.51 -1.10 (-1.09%)
Streaming Delayed Price Updated: 12:58 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revolution Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗
 
Via Benzinga
News headline image
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration ↗
 
Via Benzinga
News headline image
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
From Revolution Medicines, Inc.
Via GlobeNewswire
News headline image
Executives Buy More Than $12M Of 3 Stocks ↗
Although US stocks closed mostly lower on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
News headline image
Revolution Medicines Earnings Preview ↗
 
Via Benzinga
Where Revolution Medicines Stands With Analysts ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗
 
Via Benzinga
News headline image
Insiders Buy More Than $19M Of 3 Stocks ↗
Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Earnings Scheduled For February 28, 2022 ↗
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2022 ↗
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
News headline image
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday ↗
  WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Earnings Outlook For Revolution Medicines ↗
  Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. 
Via Benzinga
News headline image
$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying ↗
Although US stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Earnings Scheduled For August 9, 2022 ↗
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. 
Via Benzinga
News headline image
Revolution Medicines Stock Is Getting Hammered: Here's Why ↗
Revolution Medicines Inc (NASDAQ: RVMD) shares are trading lower by 11.25% to $21.82 Wednesday morning after the company announced the pricing of its underwritten public offering of 11,500,000 shares... 
Via Benzinga
News headline image
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Investors ready to start trading early this morning will want to check out the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Revolution Medicines's Earnings Outlook ↗
Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
News headline image
7 Stocks That Insiders Are Buying Now. Should You? ↗
These stocks have seen big insider buying, but you may want to consider other factors before following suit. 
Via InvestorPlace
News headline image
Earnings Scheduled For May 9, 2022 ↗
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
Via Benzinga
News headline image
Children's Place And 2 Other Stocks Bought By Insiders ↗
Although US stock futures traded higher this morning on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Insiders Buy More Than $3B Of 4 Stocks ↗
  Although US stock futures traded lower this morning amid rising Russia-Ukraine concerns, there were a few notable insider trades. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 ↗
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
News headline image
It's a Done Deal: 365 Cannabis Sold to Akerna ↗
Viridian Capital Advisors, a leading financial advisory firm in the legal cannabis industry, today announced the sale of its clien... 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.